BioAge Labs, Inc. Securities Investigation – BIOA

Kehoe Law Firm, P.C. is investigating securities claims on behalf of investors of BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ:BIOA) who purchased BioAge stock pursuant or traceable to the registration statement for its initial public offering (“IPO”) which occurred on or about September 26, 2024.

BioAge investors who obtained their securities pursuant or traceable to the Company’s IPO are encouraged to send us a message or complete Kehoe Law Firm’s Stockholder Information Request form to discuss their rights with an attorney.

Class Action Lawsuit Filed Against BioAge

A class action lawsuit has been filed in federal court against BioAge alleging violations of federal securities laws on behalf of investors who acquired BioAge stock in connection with the Company’s September 2024 IPO.

On or about September 26, 2024, BioAge, “a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases,” conducted its IPO, selling 12,650,000 shares of common stock at $18.00 per share.

On December 6, 2024, BioAge announced the discontinuation of its STRIDES Phase 2 study of azelaprag. The company stated, among other things, that the emerging safety profile of the drug was inconsistent with its goal of a best-in-class oral obesity therapy.

Following this news, BioAge’s stock price plummeted $15.44 per share (76.85%), closing at $4.65 per share on December 9, 2024.

BioAge Shareholders: Learn More About the Securities Class Action and Your Legal Options

Investors who acquired their BioAge stock pursuant or traceable to the Company’s IPO can also contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to discuss the securities class action and receive a free, no-obligation legal evaluation.

Investors who purchased BioAge stock pursuant to the Company’s IPO have until March 10, 2025 to petition the Court for appointment as lead plaintiff. The Court typically appoints the investor with the largest financial interest who also meets the adequacy and typicality requirements. Investors who wish to discuss their rights or the lead plaintiff process are encouraged to contact our firm.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Coinbase Global, Inc. – Breach of Fiduciary Duties Investigation – COIN

Kehoe Law Firm, P.C. is investigating whether certain officers and directors of Coinbase Global, Inc. (“Coinbase” or the “Company”) (NASDAQ:COIN) breached their fiduciary duties by failing to manage Coinbase in an acceptable manner and whether Coinbase and its shareholders were harmed as a result.

The investigation concerns whether certain officers and Company board members 1) failed to disclose the true risks of digital asset loss in the event of bankruptcy; 2) engaged in risky proprietary trading using the Company’s money to trade assets to compensate for the declining prices of cryptocurrencies, thereby exposing Coinbase to increased risks of financial loss and regulatory scrutiny; and 3) whether Coinbase failed to disclose that it listed unregistered securities in violation of federal securities laws.

Coinbase Stock Investors: Learn More About the Investigation and Your Legal Options

Coinbase investors who want to learn more about the investigation or discuss potential legal claims are encouraged to send us a message or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], for a free, no-obligation legal evaluation.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Septerna, Inc. – Securities Investigation – SEPN

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Septerna, Inc. (“Septerna” or the “Company”) (NASDAQ:SEPN).

On February 18, 2025, Septerna announced “. . . its decision to discontinue the Phase 1 single- and multiple-ascending dose (SAD/MAD) clinical trial of SEP-786 in healthy volunteers. SEP-786 is an oral small molecule agonist of the parathyroid hormone 1 receptor (PTH1R) being developed for the treatment of hypoparathyroidism.”

The Company also stated that “Septerna’s decision follows the observation of two unanticipated severe (Grade 3) events of elevated unconjugated bilirubin in the MAD portion of the Phase 1 trial, both of which were without elevations in ALT, AST, and GGT liver enzyme levels.”

On this news, Septerna stock dropped more than 65% during pre-market trading on February 18, 2025.

Septerna Investors: Learn More About the Securities Investigation and Potential Legal Options

If you invested in Septerna stock and want to learn more about the investigation or discuss potential legal claims, please send us a message or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], for a free, no-obligation legal evaluation.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Atkore, Inc. – ATKR

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of Atkore Inc. (“Atkore” or the “Company”) (NYSE:ATKR) investors who acquired Atkore stock securities between February 1, 2024 and February 3, 2025, inclusive (the “Class Period”).

The investigation also concerns whether certain officers and directors of the Company breached their fiduciary duties by failing to manage Atkore in an acceptable manner and whether the Company and its shareholders were harmed as a result.

Securities Fraud Class Action Lawsuit Filed Against Atkore

On February 21, 2025, a securities fraud class action lawsuit was filed in United States District Court, Northern District of Illinois (No. 1:25-cv-1851), against Atkore pursuing remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 promulgated thereunder.

In summary, the class action lawsuit alleges that the Atkore defendants engaged in an anticompetitive price-fixing scheme that artificially inflated the price of PVC pipes; reaped significant, unsustainable financial benefits from anticompetitive conduct; and as Atkore’s price-fixing scheme was exposed, the Company and its price-fixing conspirators were no longer able to artificially inflate the price of PVC pipe, resulting in a substantial decrease in the price of PVC pipe and a negative impact on Atkore’s business and operations.

Atkore also has been named as a defendant in civil antitrust lawsuits alleging that Atkore and other U.S.-based PVC pipe manufacturers conspired to artificially inflate the price of PVC pipe.

Additionally, Atkore recently filed a Form 8-K which stated that “[o]n February 13, 2025, the Company received from the U.S. Department of Justice (“DOJ”) Antitrust Division a grand jury subpoena issued by the U.S. District Court for the Northern District of California. The subpoena calls for production of documents relating to the pricing of the Company’s PVC pipe and conduit products.”

Atkore Investors: Learn More About the Investigation and Your Legal Options

Investors who acquired their Atkore stock securities during the Class Period are encouraged to send us a message or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], for a free, no-obligation evaluation of potential legal claims.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

 

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Autodesk, Inc. – Breach of Fiduciary Duties Investigation – ADSK

Kehoe Law Firm, P.C. is investigating whether certain executive officers and directors of Autodesk, Inc. (“Autodesk” or the “Company”) (NASDAQ:ADSK) breached their fiduciary duties by failing to manage Autodesk in an acceptable manner and whether Autodesk and its shareholders were harmed as a result.

Key Issues of the Breach of Fiduciary Duties Investigation

On April 1, 2024, Autodesk announced that it was “. . . unable to file its Annual Report on Form 10-K for the year ended January 31, 2024 . . . within the prescribed time period, without unreasonable effort or expense.”

Further, the Company stated that “[a]fter the Company’s earnings release on February 29, 2024, information was brought to the attention of management, which promptly informed the Audit Committee . . . of the Board of Directors of the Company, that caused the Committee to commence an internal investigation with the assistance of outside counsel and advisors, regarding the Company’s free cash flow and non-GAAP operating margin practices.”

On April 16, 2024, Autodesk announced it would “. . . not file its Annual Report on Form 10-K for the year ended January 31, 2024 . . . within the 15-day extension period contemplated by Rule 12b-25(b) under the Securities Exchange Act of 1934, as amended, due to the ongoing investigation. Accordingly, the Company expects to receive a notice from The Nasdaq Stock Market . . . that it is not in compliance with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1).”

On April 25, 2024, Autodesk reported that “[o]n April 19, 2024, the Company received a notice . . . from The Nasdaq Stock Market LLC . . . notifying the Company that, because [Autodesk] is delinquent in filing its Form 10-K, the Company no longer complies with Nasdaq Listing Rule 5250(c)(1) . . ., which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the SEC.”

On June 3, 2024, Autodesk announced that it had reassigned its Chief Financial Officer (“CFO”), after an internal accounting investigation around treatment of its free cash flow and operating margins.

Autodesk also “. . . disclosed its practice of incentivizing customers to adopt multiyear upfront billing arrangements. It has also acknowledged that discounted multiyear upfront contracts reduce revenue and lower billings in out years. Though prior to fiscal year 2024, the company did not quantify free cash flow attributable to multiyear upfront billings, it has noted the contribution of upfront collections to fluctuations in the company’s quarterly reported long-term deferred revenue.”

Investors of Autodesk Stock: Learn More About the Investigation and Your Legal Options 

If you are an Autodesk investor and want to learn more about the investigation or discuss potential legal claims, please send us a message or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], for a free, no-obligation legal evaluation.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

 

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Pagaya Technologies Securities Investigation – PGY

Kehoe Law Firm, P.C. is investigating securities claims on behalf of investors of Pagaya Technologies Ltd. (“Pagaya”) (NASDAQ:PGY) for potential violations of federal securities laws.

Investing.com reported that Pagaya stock “. . . shares fell 6% following a short report from Iceberg Research that criticized the fintech company’s financial practices and management history. Iceberg Research publicly announced its short position, claiming that Pagaya has used third-party funds to hide significant losses.”

The Iceberg Research report, according to Investing.com “. . . detailed how Pagaya underwrites consumer loans that were originally rejected by its partners due to high risk. It then sells the majority of these loans through asset-backed securities (ABS) to institutional investors. Iceberg Research highlighted a pattern of questionable management decisions and potential conflicts of interest, pointing to the involvement of Pagaya’s CTO Avital Pardo in a previously collapsed company and President Sanjiv Das’s history of overlooking misconduct.”

Shares of Pagaya stock were down more than 11% during intraday trading on February 11, 2025.

Pagaya Technologies Investors May Have Legal Claims 

Investors of Pagaya Technologies stock are encouraged to send us a message or contact John Kehoe, Esq., (215) 792-6676, Ext. 801, [email protected], [email protected], to learn more about the Pagaya Technologies securities class action investigation and receive a free, no-obligation evaluation of potential legal claims.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

 

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]